A new blood test being worked on can detect 8 common cancer types in a way that is less invasive than other tests, said Jeanne Tie, MBChB, FRACP, MD, medical oncologist and associate professor at the Walter+Eliza Hall Institute of Medical Research.
A new blood test being worked on can detect 8 common cancer types in a way that is less invasive than other tests, said Jeanne Tie, MBChB, FRACP, MD, medical oncologist and associate professor at the Walter+Eliza Hall Institute of Medical Research.
Transcript
You are working on a blood test that could detect early stages of cancer. How does the test work and how is it advanced beyond current tests that are already in use?
So, the CancerSEEK blood test is a combination of circulating tumor DNA analysis—so using genotyping in patients' blood—in addition to protein bar marker in the blood to detect 8 common cancer types. What we’ve shown is that this blood test can detect up to about maybe 70% to 80% of current, common cancer types that doesn’t have available screening method.
What it offers is that because it is a simple blood test it is much less invasive than other screening tests such as fecal occult blood is for bowel cancer. The blood test can also locate the tumor type to top 2 location which will allow clinicians then to focus the subsequent investigation such as [computerized tomography] scan or gastropexy based on the blood test result.
Obviously, it is a proof of concept study, so it isn’t until randomized trial can demonstrate in a general, noncancer population that this blood test can pick up cancer and compared to not doing the blood test, I don’t think it’s ready to be used in the clinic, but it is certainly a first step towards a very exciting era.
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More
It Take a Village in Cancer Care: A Q&A With David Nguyen, MD
July 23rd 2025David Nguyen, MD, medical oncologist with Tufts Medicine and Lowell General Hospital, discusses the evolving landscape of advanced cancer treatments like chimeric antigen receptor T-cell therapy and bispecific antibodies
Read More
Best of Managed Care Cast: Top 5 Episodes From the First Half of 2025
July 18th 2025These interviews are the top episodes, by listens, from among the 21 podcast episodes The American Journal of Managed Care® produced over the first half of 2025. Give them all another listen, and perhaps learn something new.
Read More